ABVC BioPharma, Inc. Deferred Foreign Income Tax Expense (Benefit)
ABVC BioPharma, Inc. (ABVC) reported Deferred Foreign Income Tax Expense (Benefit) of $115.67 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredForeignIncomeTaxExpenseBenefit · last filed 2025-04-15
- ABVC BioPharma, Inc. deferred foreign income tax expense (benefit) for the quarter ending 2023-12-31 was $34.97K, a 96.36% decline year-over-year.
- ABVC BioPharma, Inc. deferred foreign income tax expense (benefit) for the quarter ending 2023-09-30 was -$999.00, a 129.19% decline year-over-year.
- ABVC BioPharma, Inc. deferred foreign income tax expense (benefit) for the quarter ending 2022-12-31 was $962.07K.
- ABVC BioPharma, Inc. deferred foreign income tax expense (benefit) for the quarter ending 2022-09-30 was $3.42K.
- ABVC BioPharma, Inc. deferred foreign income tax expense (benefit) for fiscal 2023 was $115.67K, a 85.46% decline from fiscal 2022.
- ABVC BioPharma, Inc. deferred foreign income tax expense (benefit) for fiscal 2022 was $795.38K.
- ABVC BioPharma, Inc. deferred foreign income tax expense (benefit) for fiscal 2021 was -$187.06K.
| Period end | Deferred Foreign Income Tax Expense (Benefit) 3 month | Deferred Foreign Income Tax Expense (Benefit) 6 month | Deferred Foreign Income Tax Expense (Benefit) 9 month | Deferred Foreign Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2023-12-31 | $34.97K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $33.97K derived: sum of 2 quarters · filed 2025-04-15 | $115.67K 10-K · filed 2025-04-15 | |
| 2023-09-30 | -$999.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-15 | $80.70K 10-Q · filed 2023-11-15 | ||
| 2023-06-30 | $81.69K 10-Q · filed 2023-08-14 | |||
| 2022-12-31 | $962.07K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $965.50K derived: sum of 2 quarters · filed 2024-03-13 | $883.04K derived: sum of 3 quarters · filed 2024-03-13 | $795.38K 10-K · filed 2024-03-13 |
| 2022-09-30 | $3.42K 10-Q · filed 2022-11-14 | -$79.03K derived: sum of 2 quarters · filed 2023-08-14 | -$166.70K 10-Q · filed 2023-11-15 | -$165.90K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-06-30 | -$82.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$169.32K 10-Q · filed 2023-08-14 | -$169.32K derived: sum of 3 quarters · filed 2023-08-14 | -$244.99K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$86.87K 10-Q · filed 2023-05-15 | -$86.87K derived: sum of 2 quarters · filed 2023-05-15 | -$162.53K derived: sum of 3 quarters · filed 2023-05-15 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$75.67K derived: sum of 2 quarters · filed 2023-03-31 | -$187.06K 10-K · filed 2023-03-31 | |
| 2021-09-30 | -$75.67K 10-Q · filed 2022-11-14 | -$187.06K 10-Q · filed 2022-11-14 |